Journals / Dicle Tıp Dergisi / 2014 / Cilt: 41 - Sayı: 4

Uric acid levels in metabolically healthy and unhealthy obese patients

Metabolik olarak sağlıklı ve sağlıksız obez hastalarda ürik asit seviyeleri

Pages
676–680
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In the fact of determined relation of uric acid with the insulin resistance and significant difference of uric acid levels between metabolically healthy and nonhealthy obese groups, uric acid can be considered as a cheap, accessible and sensitive parameter for metabolic syndrome and cardiovascular risk factor in obese individuals.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, we aimed to investigate the difference of uric acid levels between metabolically healthy and unhealthy obese individuals.
📊
Key Findings & Data:Methods: Patients of internal medicine and endocrinology outpatient clinics who admitted with the complaint of overweight were separated into two groups, by diagnostic criteria for metabolic syndrome, as metabolically healthy obese and metabolically unhealthy obese individuals.
💡
Conclusion & Impact:Conclusion: In the fact of determined relation of uric acid with the insulin resistance and significant difference of uric acid levels between metabolically healthy and nonhealthy obese groups, uric acid can be considered as a cheap, accessible and sensitive parameter for metabolic syndrome and cardiovascular risk factor in obese individuals.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, we aimed to investigate the difference of uric acid levels between metabolically healthy and unhealthy obese individuals. Methods: Patients of internal medicine and endocrinology outpatient clinics who admitted with the complaint of overweight were separated into two groups, by diagnostic criteria for metabolic syndrome, as metabolically healthy obese and metabolically unhealthy obese individuals. Total of 193 women aged between 18 to 70 years were enrolled into study. Results: Statistically significant differences were determined regarding waist circumference (p=0.038), HOMAIR (p<0.001) and uric acid levels (p=0.001) between metabolically healthy obese and metabolically unhealthy obese patients while high-sensitive CRP levels (p>0.05) were not differ between these groups. When patients were separated into two groups according to uric acid median, the rate of metabolic syndrome found to be increased in high uric acid group (p=0.021). A correlation analysis showed that uric acid was significantly associated with number of metabolic syndrome parameters (r=0.270, p<0.001) beyond presence of metabolic syndrome. Conclusion: In the fact of determined relation of uric acid with the insulin resistance and significant difference of uric acid levels between metabolically healthy and nonhealthy obese groups, uric acid can be considered as a cheap, accessible and sensitive parameter for metabolic syndrome and cardiovascular risk factor in obese individuals.

Özet

Amaç: Çalışmamızda, metabolik olarak sağlıklı ve sağlıksız obez bireyler arasında serum ürik asit seviyelerindeki farkların araştırılması amaçlanmıştır. Yöntemler: Çalışmamızda; hastanemiz iç hastalıkları ve endokrinoloji polikliniklerine kilo fazlalığı şikayeti ile baş- vuran hastalarda, metabolik sendrom tanı kriterleri araş- tırılarak, metabolik olarak sağlıklı obezler ve sağlıksız obezler olarak iki grup oluşturuldu. Çalışmaya yaşları 18 ile 70 arasında değişen, toplam 193 kadın katılımcı alındı. Bulgular: Metabolik olarak sağlıklı obezler ve metabolik olarak sağlıksız obezler arasında bel çevresi (p=0,038), HOMA-IR (p 0,05). Hastalar ürik asit median değerine göre iki gruba ayrıldığında, ürik asit yüksek grupta, metabolik sendrom rastlanma oranının arttığı tespit edildi (p=0,021). Metabolik sendrom ile ilişkisinin yanında, ürik asidin, korelasyon analizinde, metabolik sendrom kriterlerinin sayı- sı ile de anlamlı ilişki tespit edildi (r=0,270, p<0,001). Sonuç: İnsülin direnci ile yakın ilişkisi, metabolik olarak sağlıklı olan ve olmayan obez gruplar arasında fark oluş- turduğu dikkate alındığında, ürik asit, obez bireylerde, bir metabolik sendrom kriteri ve kardiyovasküler hastalık risk belirteci olarak kullanılabilecek ucuz, ulaşılabilir ve duyarlı bir parametredir

🔖

Cite This Article

AKBAŞ, E. M., ÖZÇİÇEK, A., ÖZÇİÇEK, F., DEMİRTAŞ, L., TİMUROĞLU, A., GÜNGÖR, A., AKBAŞ, N. (2014). Uric acid levels in metabolically healthy and unhealthy obese patients. Dicle Tıp Dergisi, Cilt: 41 - Sayı: 4, 676–680. https://ajindex.com/articles/348982

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Karelis AD. Metabolically healthy but obese individuals. Lancet 2008;372:1281-1283
  2. Yoo HK, Choi EY, Park EW, et al. Comparison of metabolic characteristics of metabolically healthy but obese (mho) middle-aged men according to different criteria. Korean J Fam Med 2013;34:19-26
  3. Ciarla S, Struglia M, Giorgini P, et al. Serum uric acid levels and metabolic syndrome. Arch Physiol Biochem 2014;120:119-122
  4. Li Y, Chen S, Shao X, et al. Association of uric acid with metabolic syndrome in men, premenopausal women and postmenopausal women. Int J Environ Res Public Health 2014;11:2899-2910
  5. Ndrepepa G, Braun S, King L, et al. Uric acid and prognosis in angiography-proven coronary artery disease. Eur J Clin Invest 2013;43:256-266
  6. Deveci O, Kabakci G, Okutucu S, et al. The association between serum uric acid level and coronary artery disease. Int J Clin Pract 2010;64:900-907
  7. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419
  8. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752
  9. Bhurosy T, Jeewon R. Overweight and obesity epidemic in developing countries: A problem with diet, physical activity, or socioeconomic status? Sci World J 2014;2014: 964236
  10. Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2011; 35: 971-981
  11. Taksali SE, Caprio S, Dziura J, et al. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Diabetes 2008;57:367-371
  12. Pajunen P, Kotronen A, Korpi-Hyovalti E, et al. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC Public Health 2011;11:754
  13. Shiina Y, Homma Y. Relationships between the visceral fat area on CT and coronary risk factor markers. Intern Med 2013; 52: 1775-1780
  14. Roriz AK, Mello AL, Guimaraes JF, et al. Imaging assessment of visceral adipose tissue area and its correlations with metabolic alterations. Arq Bras Cardiol 2010;95:698-704
  15. Bedir A, Topbas M, Tanyeri F, et al. Leptin might be a regulator of serum uric acid concentrations in humans. Jpn Heart J 2003;